Screener
Cytokinetics CYTK Return on equity
Discontinued — last reported Q2 '22
Return on equity at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
Based on trailing twelve months.
The source filing: Cytokinetics’s 10-Q, filed August 5, 2022. Open the filing →
- Filed
- Aug 5, 2022, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2022
- Calendar quarter
- Q2 2022
- Accession
- 0000950170-22-015117
FAQ
- What is Cytokinetics's return on equity?
- Cytokinetics (CYTK) reported return on equity of -337.6% in Q2 2022.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Cytokinetics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude